A5047587888- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Childhood Cancer Survivors' Quality of Life
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Blood groups and transfusion
- Platelet Disorders and Treatments
- Hemoglobinopathies and Related Disorders
- Neutropenia and Cancer Infections
- Blood disorders and treatments
- Immunodeficiency and Autoimmune Disorders
- Parvovirus B19 Infection Studies
- Kruppel-like factors research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Liver Diseases and Immunity
- Systemic Sclerosis and Related Diseases
- Clinical Laboratory Practices and Quality Control
- Cancer Treatment and Pharmacology
- COVID-19 and healthcare impacts
- Complement system in diseases
- Peripheral Neuropathies and Disorders
- Healthcare Systems and Reforms
King Saud bin Abdulaziz University for Health Sciences
2022-2024
National Guard Health Affairs
2013-2023
King Abdullah International Medical Research Center
2022-2023
Saudi Center for Organ Transplantation
2023
King Abdulaziz Medical City
2017-2022
Al Noor Hospitals
2022
King Fahad Hospital Jeddah
2015
University Hospitals Birmingham NHS Foundation Trust
2012
Queen Elizabeth Hospital
2007-2011
King's College Hospital
2002-2004
Summary. Serum erythropoietin (Epo) values were estimated in samples from 125 patients with erythrocytosis to examine the specificity and sensitivity of reduced raised diagnosis polycythaemia vera (PV) secondary (SE) respectively. Additionally, Epo 49 primary thrombocythaemia (PT) determine whether altered. We found high (92%) moderate (64%) low serum (below reference range) PV, also poor (47%) SE. Raised not observed PV Hb > 14·0 g/dl only one patient a relatively recovering...
Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report case COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.
No study has been published yet in the Arab world regarding response and outcome of imatinib patients with chronic myeloid leukemia (CML). This evaluated a total 122 CML treated between 2001 2012. Survival, hematologic, cytogenetic molecular responses adverse events were assessed. The 5-year overall survival (OS), event free (EFS) progression-free (PFS) rates were: 95.4 ± 2.3%, 81.4 4.6% 90.8 3.2%, respectively. Significant differences OS (p = 0.001), EFS 0.001) PFS noted when stratified by...
To review and assess the efficiency of pre-emptive plerixafor administration for poor mobilization (PM) to (≥2×106 CD34+ cells/kg) in patients who received autologous stem cell transplantation lymphoma multiple myeloma (MM) at Department Adult Hematology/Blood Marrow Transplant, Princess Noorah Oncology Center, King Abdulaziz Medical City, Jeddah, Saudi Arabia, over past 7 years.This retrospective study evaluated all with MM undergoing peripheral blood collection our institution between...
e18527 Background: Studies have shown superior outcomes of AYA Ph-ALL when treated with pediatric or pediatric-inspired protocol. Since 2003 we used a modified Children’s Oncology Group (COG) protocol to treat aiming improve outcomes. Methods: This study involved 67 consecutive patients aged 14-35 years diagnosed between October and March 2016. Patients precursor B ALL, CNS1/CNS2, negative day 29 minimal residual disease (MRD-) received single interim maintenance (IM) delayed intensification...
Acquired thrombotic thrombocytopenic purpura (aTTP) is a life-threatening microangiopathy usually characterized by microangiopathic hemolytic anemic, thrombocytopenia, and end-organ ischemia associated with disseminated microvascular platelet-rich thrombi severe deficiency (activity <10%) of A Disintegrin-like And Metalloprotease ThromboSpondin Type 1 Motif No. 13 (ADAMTS13). It medical emergency, if left untreated, acute mortality as high 90%. This review article narrative based on...